|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23.02.26 - 22:51
|
Novanta Announces Financial Results for the Fourth Quarter and Full Year 2025 (Business Wire)
|
|
|
Fourth Quarter 2025 GAAP Revenue increased 9% to $258 million, and GAAP Diluted EPS was $0.45
Fourth Quarter 2025 Adjusted Diluted EPS was $0.91, increased 20%, and Adjusted EBITDA was $61 million, increased 17%
Full Year 2025 GAAP Revenue increased 3% to $981 million, and GAAP Diluted EPS was $1.47
Full Year 2025 Adjusted Diluted EPS was $3.29, and Adjusted EBITDA was $221 million
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the fourth quarter and full year 2025.
Financial Highlights
Three Months Ended
December 31,
Year Ended December 31,
(In millions, except per share amounts)
2025
2024
2025
2024
GAAP
Revenue
$
258.3
$
238.1
$
980.6
$
949.2
Operating Income
$
24.8
$
26.7
$
94.0
$
110.6
Net Income
$
17.5
$
16.5
$
53.8
...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|